Cetuximab in Treating Patients With Persistent or Recurrent Cervical Cancer

Clinical trial NCT00499031 · COMPLETED

Trial details

NCT number: NCT00499031
Sponsor: Gynecologic Oncology Group
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Cervical Squamous Cell Carcinoma Recurrent Cervical Carcinoma

Start date: 2007-06-01
Primary completion: 2012-01-01
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.